Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Healthequity (HQY) over the last 12 years, with Q4 2025 value amounting to $85.0 million.

  • Healthequity's Other Non-Current Assets rose 2547.79% to $85.0 million in Q4 2025 from the same period last year, while for Oct 2025 it was $85.0 million, marking a year-over-year increase of 2547.79%. This contributed to the annual value of $71.6 million for FY2025, which is 546.06% up from last year.
  • Healthequity's Other Non-Current Assets amounted to $85.0 million in Q4 2025, which was up 2547.79% from $80.4 million recorded in Q3 2025.
  • Over the past 5 years, Healthequity's Other Non-Current Assets peaked at $85.0 million during Q4 2025, and registered a low of $37.4 million during Q1 2021.
  • For the 5-year period, Healthequity's Other Non-Current Assets averaged around $57.4 million, with its median value being $52.6 million (2023).
  • Per our database at Business Quant, Healthequity's Other Non-Current Assets soared by 3310.26% in 2022 and then surged by 349.62% in 2025.
  • Healthequity's Other Non-Current Assets (Quarter) stood at $44.9 million in 2021, then increased by 7.22% to $48.2 million in 2022, then grew by 8.92% to $52.4 million in 2023, then grew by 29.17% to $67.7 million in 2024, then grew by 25.48% to $85.0 million in 2025.
  • Its last three reported values are $85.0 million in Q4 2025, $80.4 million for Q3 2025, and $71.3 million during Q2 2025.